Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Gait Retraining Enhances Athletes' Technique (GREAT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03918681
Recruitment Status : Recruiting
First Posted : April 17, 2019
Last Update Posted : September 10, 2019
Sponsor:
Collaborator:
Telemedicine & Advanced Technology Research Center
Information provided by (Responsible Party):
Erin M. Miller, Keller Army Community Hospital

Brief Summary:
The participant population for this study will be a convenience sample of 40 active duty soldiers and cadets at West Point, New York (NY) who are recovering from anterior cruciate ligament reconstruction (ACLR) and are cleared to return to run by their medical provider. Two groups will be utilized in this pre-test, post-test, single-blind randomized controlled trial study design. The purpose of this study is to determine if patients recovering from ACLR benefit from running gait retraining to adopt a forefoot strike pattern and 5-10% increase in step rate when compared to a traditional walk to run program.

Condition or disease Intervention/treatment Phase
Anterior Cruciate Ligament Injury Knee Osteoarthritis Other: Therapeutic Intervention Not Applicable

Detailed Description:
The participant population for this study will be a convenience sample of 40 active duty soldiers and cadets at West Point, NY who are recovering from Anterior Cruciate Ligament Reconstruction (ACLR) and are cleared to return to run by their medical provider. Two groups will be utilized in this repeated measures, single-blind, randomized controlled trial study design. The purpose of this study is to determine if patients recovering from ACLR benefit from running gait retraining when compared to a traditional walk-to-run program. Patient reported outcome measures, running kinetic data and running kinematic data, along with biomarkers of cartilage turnover and clinical outcomes will be assessed in two groups of post-operative ACLR patients. All participants, regardless of group, will be instructed in a 4-week home exercise program to ensure runners have adequate strength prior to returning to full running activities. They will be provided an instructional handout and compliance log at the date of their initial running biomechanical assessment. The home exercise program will consist of exercises focused on stretching and strengthening of the hip, knee, calf and foot musculature. One group will receive technology assisted clinician guided gait retraining to reduce lower extremity loading parameters (intervention) while the control group will return to running with a traditional return to run program (control). Regardless of group, all runners will have their running form and foot strike pattern analyzed using an instrumented treadmill and high-speed motion capture initially, at the pre-intervention, post-intervention, and follow-up time point. During the intervention period, regardless of group, all runners will complete in-clinic follow-ups with their study assigned medical provider. During these visits the control group will only receive standard run program feedback. During these visits the intervention group will receive technology-guided clinician-assisted gait retraining cues to reduce ground reaction forces during running. Kinetic data, kinematic data, and perceived running pain and running function will be collected at the pre-intervention, post-intervention and follow-up timepoints to include average vertical loading rate (AVLR), AVLR symmetry, impulse, foot strike pattern (FSP), contact time, step length, step rate, Visual Analog Scale for Running Pain during running, Visual Analog Scale for Running Pain worst pain, Visual Analog Scale for Running Pain during after running, Single Assessment Numeric Evaluation, Knee Injury and Osteoarthritis Outcome Score (KOOS), and University of Wisconsin Running and Recovery Index (UWRI). Biological samples will be collected from all runners regardless of group at the pre-intervention time point and the post-intervention timepoint. Biological samples will be tested using ELISA for several biomarkers of interest and the concentration of these biomarkers will be compared within and between groups over time. A pan-omics (e.g. metabolomics, proteomics, and transcriptomics) approach will be used to test for novel biomarkers that will also compare within and between groups over time. Our military service members are at greater risk of ACL injury, greater risk of early onset knee Osteoarthritis (OA), and are required to maintain high levels of fitness to remain in the military. It is therefore clinically important to identify interventions to improve patient reported outcomes, return to duty rates, and reduce lower extremity loading parameters in military service members returning to run after ACLR.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: pre-test, post-test, single-blind randomized controlled trial study design
Masking: Single (Outcomes Assessor)
Masking Description: The outcomes assessors will be blind to treatment group.
Primary Purpose: Treatment
Official Title: Gait Retraining Enhances Athletes' Technique: GREAT After Anterior Cruciate Ligament Reconstruction
Actual Study Start Date : August 1, 2019
Estimated Primary Completion Date : January 1, 2021
Estimated Study Completion Date : March 1, 2021

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Intervention Group
The experimental group participants (approximately 20 participants) will receive, a standard graduated return-to-run program, a 4-week lower-extremity exercise program, and an activity log to track exercise progress. Participants will be instructed to follow-up with their research physical therapist once a week for the first 4 weeks and then every other week until the run progression is completed. During follow-ups experimental group participants will receive gait retraining cues to transition to a NRFS running pattern.
Other: Therapeutic Intervention
Instruction for all participants in the experimental group will begin with transitioning foot strike pattern from a rearfoot strike to a non-rearfoot strike running pattern (NRFS) and increasing preferred step rate by 5-10%. Each participant program thereafter will be progressed individually according to the clinical investigators follow up assessments of running mechanics and participant pain and function with running. Intervention gait retraining sessions will include drills for reinforcement to include soft landing single leg bounding, adequate time to practice, and pre-class and post-class video assessment with feedback.
Other Name: Gait Retraining

No Intervention: Control Group
The control group participants (approximately 20 participants) will receive, a standard graduated return-to-run program, a 4-week lower-extremity exercise program, and an activity log to track exercise progress. Participants will be instructed to follow-up with their research physical therapist once a week for the first 4 weeks and then every other week until the run progression is completed. During follow-ups control group participants will not receive any gait retraining cues and will only be instructed on standard of care return to run metrics to include volume, load, and duration of running.



Primary Outcome Measures :
  1. Visual Analogue Scale (VAS) During Running Pain [ Time Frame: Change from Pre-Intervention (Initial) to Post-Intervention (up to 10 weeks). Change from Pre-Intervention (Initial) to Follow-Up (Up to 15 weeks) ]
    VAS, measures self-reported pain, scored on a 0-10 scale with 0 being no pain and 10 being worst pain imaginable.

  2. Knee Injury and Osteoarthritis Outcome Score (KOOS) [ Time Frame: Change from Pre-Intervention (Initial) to Post-Intervention (up to 10 weeks). Change from Pre-Intervention (Initial) to Follow-Up (Up to 15 weeks) ]
    Subjective Knee Evaluation Form


Secondary Outcome Measures :
  1. University of Wisconsin Running and Recovery Index (UWRI) [ Time Frame: Change from Pre-Intervention (Initial) to Post-Intervention (up to 10 weeks). Change from Pre-Intervention (Initial) to Follow-Up (Up to 15 weeks) ]
    UWRI, scored on a scale from 0-36 with 36 equaling completion of running function and a score of 0 equating to inability to run.

  2. CPII Serum Biomarker Concentration [ Time Frame: Change from Pre-Intervention (Initial) to Post-Intervention (up to 10 weeks). Change from Pre-Intervention (Initial) to Follow-Up (Up to 15 weeks) ]
    Blood specimen biomarker associated with knee osteoarthritis and cartilage/bone turnover.

  3. C1 Serum Biomarker Concentration [ Time Frame: Change from Pre-Intervention (Initial) to Post-Intervention (up to 10 weeks). Change from Pre-Intervention (Initial) to Follow-Up (Up to 15 weeks) ]
    Blood specimen biomarker associated with knee osteoarthritis and cartilage/bone turnover.

  4. 2C Serum Biomarker Concentration [ Time Frame: Change from Pre-Intervention (Initial) to Post-Intervention (up to 10 weeks). Change from Pre-Intervention (Initial) to Follow-Up (Up to 15 weeks) ]
    Blood specimen biomarker associated with knee osteoarthritis and cartilage/bone turnover.

  5. C2C Serum Biomarker Concentration [ Time Frame: Change from Pre-Intervention (Initial) to Post-Intervention (up to 10 weeks). Change from Pre-Intervention (Initial) to Follow-Up (Up to 15 weeks) ]
    Blood specimen biomarker associated with knee osteoarthritis and cartilage/bone turnover.

  6. CTX-1 Serum Biomarker Concentration [ Time Frame: Change from Pre-Intervention (Initial) to Post-Intervention (up to 10 weeks). Change from Pre-Intervention (Initial) to Follow-Up (Up to 15 weeks) ]
    Blood specimen biomarker associated with knee osteoarthritis and cartilage/bone turnover.

  7. NTX Serum Biomarker Concentration [ Time Frame: Change from Pre-Intervention (Initial) to Post-Intervention (up to 10 weeks). Change from Pre-Intervention (Initial) to Follow-Up (Up to 15 weeks) ]
    Blood specimen biomarker associated with knee osteoarthritis and cartilage/bone turnover.

  8. Average Vertical Loading Rate (AVLR) [ Time Frame: Change from Pre-Intervention (Initial) to Post-Intervention (up to 10 weeks). Change from Pre-Intervention (Initial) to Follow-Up (Up to 15 weeks) ]
    A vertical ground reaction force measure that indicates how quickly force is being applied to the body.


Other Outcome Measures:
  1. Patient Specific Functional Scale (PSFS) [ Time Frame: Change from Pre-Intervention (Initial) to Post-Intervention (up to 10 weeks). Change from Pre-Intervention (Initial) to Follow-Up (Up to 15 weeks) ]
    PSFS, scored on a 0-10 scale with six pre-filled items: walking, running on level ground less than 2 miles, running uphill, running downhill, running on level ground greater than 2 miles, and hopping/jumping).

  2. Single Assessment Numeric Evaluation (SANE) [ Time Frame: Change from Pre-Intervention (Initial) to Post-Intervention (up to 10 weeks). Change from Pre-Intervention (Initial) to Follow-Up (Up to 15 weeks) ]
    SANE, scored on a 0-100% scale with 100% equaling completion of function

  3. Peak Vertical Ground Reaction Force [ Time Frame: Change from Pre-Intervention (Initial) to Post-Intervention (up to 10 weeks). Change from Pre-Intervention (Initial) to Follow-Up (Up to 15 weeks) ]
    A vertical ground reaction force measure that indicates how the peak force applied to the body.

  4. Braking Force [ Time Frame: Change from Pre-Intervention (Initial) to Post-Intervention (up to 10 weeks). Change from Pre-Intervention (Initial) to Follow-Up (Up to 15 weeks) ]
    A vertical ground reaction force measure that indicates the amount of anterior force applied to the body.

  5. Vertical Center of Mass Displacement [ Time Frame: Change from Pre-Intervention (Initial) to Post-Intervention (up to 10 weeks). Change from Pre-Intervention (Initial) to Follow-Up (Up to 15 weeks) ]
    The difference between the highest vertical and lowest vertical point achieved during a running stride.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Able and willing to give informed consent
  2. Between 18-50 years of age
  3. Active duty Soldier or cadet
  4. History of Anterior Cruciate Ligament Reconstruction in the last 18 months
  5. Cleared to return to run by their Department of Defense medical provider (primary care physician, orthopedic surgeon, physical therapist, or athletic trainer)
  6. Ability to perform 20 unassisted single leg heel raises bilaterally
  7. Ability to perform 10 pain-free, symmetrical, single-leg squats to between 45-60 degrees bilaterally
  8. Ability to perform 20 pain-free single leg hops in place bilaterally

Exclusion Criteria:

  1. Currently on an Army running limiting profile
  2. Concomitant Posterior Cruciate Ligament or Lateral Cruciate Ligament injury
  3. Concomitant meniscectomy >50%
  4. History of inflammatory arthritis or gout
  5. History of ACL injury to either knee
  6. History of major lower-extremity joint injury and/or surgery
  7. Known pregnancy currently or in the previous 6 months

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03918681


Contacts
Layout table for location contacts
Contact: Erin M Miller, MS, ABD 845-987-0029 erin.florkiewicz@gmail.com
Contact: Michael Crowell, DSc 845-938-3067 michaelcrowell99@gmail.com

Locations
Layout table for location information
United States, New York
Keller Army Community Hospital Recruiting
West Point, New York, United States, 10996
Contact: Erin M Miller, MS, ABD    845-987-0029    erin.florkiewicz@gmail.com   
Contact: Michael Crowell, DSc    845-938-3067    michaelcrowell99@gmail.com   
Principal Investigator: Erin M Miller, MS,ABD         
Sub-Investigator: Michael Crowell, DSc         
Sub-Investigator: Donald Goss, PhD         
Sub-Investigator: John Mason, DSc         
Sponsors and Collaborators
Keller Army Community Hospital
Telemedicine & Advanced Technology Research Center
Investigators
Layout table for investigator information
Principal Investigator: Erin M Miller, MS, ABD Keller Army Community Hospital
Layout table for additonal information
Responsible Party: Erin M. Miller, Research Program Manager, Keller Army Community Hospital
ClinicalTrials.gov Identifier: NCT03918681    
Other Study ID Numbers: 19KACH001
First Posted: April 17, 2019    Key Record Dates
Last Update Posted: September 10, 2019
Last Verified: September 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Erin M. Miller, Keller Army Community Hospital:
Running
Gait Retraining
Return to Run
ACLR
Loading
Additional relevant MeSH terms:
Layout table for MeSH terms
Osteoarthritis, Knee
Anterior Cruciate Ligament Injuries
Osteoarthritis
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Knee Injuries
Leg Injuries
Wounds and Injuries